Faren Xie
Nanjing, 210023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Identification and screening of bioactive peptides against nephropathy derived from Mantidis Oötheca based on complement C3 inhibition.
Journal: Chinese journal of natural medicines
Published: February 08, 2025
Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB Reinfection.
Journal: Vaccines
Published: March 25, 2024
Risk of reinfection and severity with the predominant BA.5 Omicron subvariant China, from December 2022 to January 2023.
Journal: Emerging microbes & infections
Published: December 06, 2023
Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study.
Journal: Hepatology international
Published: September 22, 2023
Celastrol: An Update on Its Hepatoprotective Properties and the Linked Molecular Mechanisms.
Journal: Frontiers in pharmacology
Published: January 19, 2022
Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study.
Journal: Hepatology international
Published: January 15, 2022
Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 21, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026